The present invention relates to a melanin concentrating hormone antagonist compound of Formula I: (I) wherein Ar.sup.1, Ar.sup.2, Ar.sup.3, L.sup.1, L.sup.2 and Q areas defined, or a pharmaceutically acceptable salt, solvate, enantiomer or mixture of diastereomers thereof useful in the treatment, prevention or amelioration of symptoms associated with obesity and Related Diseases.

 
Web www.patentalert.com

< Novel substituted arylhexadienoic acids and esters thereof which can be used for thetreatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositios comprising them and processes for the preparation of them

< 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

> Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia

> Method

~ 00245